Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 12,038 shares at $104.25 ($1.3M) on 2025-02-24, disclosed to the SEC on 2025-02-25.
Scheduled sale ($1.3M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.25 | 4,675 | $487K | 38.9% |
| 2 | $104.25 | 4,675 | $487K | 38.9% |
| 3 | $104.00 | 2,688 | $280K | 22.3% |
| Total | $104.19 avg | 12,038 | $1.3M | 100% |
| Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |
| BSX | SELL | 2024-03-19 | $1.9M | — | Filing → |